from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0110/-

LFCtreatmentdescriptionclass of inhibitor

-0.269

Amikacinug/mL Amikacintranslation

-0.243

Cap5-10ug/mL Capreomycintranslation

-0.554

Rox10-50 ug/mL Roxithromycintranslation

-0.257

SM2-5 ug/mL Streptomycintranslation

-0.227

Tet5-10 ug/mL Tetracyclinetranslation

0.553

Rif0.2-5ug/mL Rifampicintranscription

0.723

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.004

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.328

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.825

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.261

Clofazimine10-13 ug/mL Clofaziminerespiration

0.350

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.694

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.442

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.652

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.509

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.177

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.260

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.988

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.083

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.780

KCN5-20 ug/mL Potassium cyaniderespiration

0.278

NaN30.2-2 mM Sodium aziderespiration

-0.773

Nigericin50 uM Nigericinrespiration

0.647

TRC10-150 ug/mL Triclosanrespiration

-0.798

TRZ10-25 ug/mL Thioridazinerespiration

-2.026

Valinomycin0.5-10 uM Valinomycinrespiration

-1.236

ZnSO42 mM ZnSO4respiration

-1.098

menadione6-10 ug/mL Menadionerespiration

-0.202

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.439

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.713

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.940

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.843

NRP_1Non-replicating persistence stage 1dosRassociated

0.013

Amp0.2mg/mL AmpicillincellWall

-0.152

Cephalexin20-100 ug/mL CephalexincellWall

-0.125

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.461

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.015

EMB10-20 ug/mL EthambutolcellWall

-0.172

Eta12-40 ug/mL EthionamidecellWall

-0.275

INH0.2-0.4 ug/mL IsoniazidcellWall

0.247

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.291

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.876

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.676

BZA0.12 mg/mL BenzamidearomaticAmides

0.779

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.546

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.105

H2O24 mM hydrogen peroxideDNAdamaging

0.228

Levo10 ug/mL LevofloxacinDNAdamaging

0.648

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.664

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.411

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.259

UVUV-irradiationDNAdamaging

-1.291

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.046

Antimycin12.5-50 ug/mL Antimycin A?

-0.676

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.494

PA_110-50 ug/mL Antitubercular compound PA-1?

0.026

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.090

PA8240.2-2 ug/mL PA-824?

0.505

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.047

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.777

Verapamil50 uM Verapamil?

-0.417

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.372

methoxatin10-20 ug/mL Methoxatin?